224 related articles for article (PubMed ID: 16381183)
21. Treatment of cerebral vasospasm after subarachnoid hemorrhage--a review.
Wu CT; Wong CS; Yeh CC; Borel CO
Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):215-22. PubMed ID: 15679131
[TBL] [Abstract][Full Text] [Related]
22. [Serious pitfalls which can be encountered in a course of hypertension-hypervolemia therapy for vasospasm].
Abe S; Wada T; Miyazaki Y; Kanki T; Hashimoto T; Nakamura N
No Shinkei Geka; 1992 Apr; 20(4):357-65. PubMed ID: 1570056
[TBL] [Abstract][Full Text] [Related]
23. Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm.
Raabe A; Zimmermann M; Setzer M; Vatter H; Berkefeld J; Seifert V
Neurosurgery; 2002 May; 50(5):1006-13; discussion 1013-4. PubMed ID: 11950403
[TBL] [Abstract][Full Text] [Related]
24. Cerebral tissue PO2 and SjvO2 changes during moderate hyperventilation in patients with severe traumatic brain injury.
Imberti R; Bellinzona G; Langer M
J Neurosurg; 2002 Jan; 96(1):97-102. PubMed ID: 11794610
[TBL] [Abstract][Full Text] [Related]
25. [Recommendations for the management of patients with aneurysmal subarachnoid hemorrhage].
Raabe A; Beck J; Berkefeld J; Deinsberger W; Meixensberger J; Schmiedek P; Seifert V; Steinmetz H; Unterberg A; Vajkoczy P; Werner C;
Zentralbl Neurochir; 2005 May; 66(2):79-91. PubMed ID: 15846536
[TBL] [Abstract][Full Text] [Related]
26. Cerebral infarction secondary to vasospasm after perimesencephalic subarachnoid hemorrhage.
Fernandez A; Bond RL; Aziz-Sultan MA; Olvey SE; Mangat HS
J Clin Neurosci; 2011 Jul; 18(7):994-6. PubMed ID: 21565507
[TBL] [Abstract][Full Text] [Related]
27. Computational modeling of HHH therapy and impact of blood pressure and hematocrit.
Robinson JS; Walid MS; Hyun S; O'Connell R; Menard C; Bohleber B
World Neurosurg; 2010; 74(2-3):294-6. PubMed ID: 21492563
[TBL] [Abstract][Full Text] [Related]
28. [Two patients treated with intra-aortic balloon pump counterpulsation after subarachnoid hemorrhage].
Sato K; Tokairin H; Kato M
Masui; 2001 Aug; 50(8):859-62. PubMed ID: 11554017
[TBL] [Abstract][Full Text] [Related]
29. The effect of nimodipine on cerebral oxygenation in patients with poor-grade subarachnoid hemorrhage.
Stiefel MF; Heuer GG; Abrahams JM; Bloom S; Smith MJ; Maloney-Wilensky E; Grady MS; LeRoux PD
J Neurosurg; 2004 Oct; 101(4):594-9. PubMed ID: 15481712
[TBL] [Abstract][Full Text] [Related]
30. Blood pressure changes after aneurysmal subarachnoid hemorrhage and their relationship to cerebral vasospasm and clinical outcome.
Faust K; Horn P; Schneider UC; Vajkoczy P
Clin Neurol Neurosurg; 2014 Oct; 125():36-40. PubMed ID: 25083804
[TBL] [Abstract][Full Text] [Related]
31. Neuroendovascular management of vasospasm following aneurysmal subarachnoid hemorrhage.
Jabbour PM; Tjoumakaris SI; Rosenwasser RH
Neurosurg Clin N Am; 2009 Oct; 20(4):441-6. PubMed ID: 19853803
[TBL] [Abstract][Full Text] [Related]
32. Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow, and oxygen utilization in humans.
Grubb RL; Raichle ME; Eichling JO; Gado MH
J Neurosurg; 1977 Apr; 46(4):446-53. PubMed ID: 845630
[TBL] [Abstract][Full Text] [Related]
33. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage.
Mori T; Katayama Y; Kawamata T; Hirayama T
J Neurosurg; 1999 Dec; 91(6):947-52. PubMed ID: 10584839
[TBL] [Abstract][Full Text] [Related]
34. Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage.
Qureshi AI; Suarez JI; Bhardwaj A; Yahia AM; Tamargo RJ; Ulatowski JA
Crit Care Med; 2000 Mar; 28(3):824-9. PubMed ID: 10752836
[TBL] [Abstract][Full Text] [Related]
35. "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
Lee KH; Lukovits T; Friedman JA
Neurocrit Care; 2006; 4(1):68-76. PubMed ID: 16498198
[TBL] [Abstract][Full Text] [Related]
36. Which H is the most important in triple-H therapy for cerebral vasospasm?
Treggiari MM; Deem S
Curr Opin Crit Care; 2009 Apr; 15(2):83-6. PubMed ID: 19276798
[TBL] [Abstract][Full Text] [Related]
37. Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage.
Musahl C; Henkes H; Vajda Z; Coburger J; Hopf N
Neurosurgery; 2011 Jun; 68(6):1541-7; discussion 1547. PubMed ID: 21311378
[TBL] [Abstract][Full Text] [Related]
38. Anesthetic considerations of selective intra-arterial nicardipine injection for intracranial vasospasm: a case series.
Avitsian R; Fiorella D; Soliman MM; Mascha E
J Neurosurg Anesthesiol; 2007 Apr; 19(2):125-9. PubMed ID: 17413999
[TBL] [Abstract][Full Text] [Related]
39. Hyperbaric oxygen therapy adjunctive to mild hypertensive hypervolemia for symptomatic vasospasm.
Kohshi K; Yokota A; Konda N; Munaka M; Yasukouchi H
Neurol Med Chir (Tokyo); 1993 Feb; 33(2):92-9. PubMed ID: 7682672
[TBL] [Abstract][Full Text] [Related]
40. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.
Liu-Deryke X; Rhoney DH
Pharmacotherapy; 2006 Feb; 26(2):182-203. PubMed ID: 16466324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
